IL6 and breast carcinoma: Ham et al. (45) showed that breast cancer-derived exosomal gp130 activates the IL-6/STAT3 pathway in macrophages and causes the expression of protumor cytokines, thus potentially tilting macrophages toward a procancer phenotype, suggesting that breast cancer-derived exosomal proteins may play a key role in cancer progression.